Proximity Work in Family Medicine Groups : the Impact of Pharmacists

Study Overview
=================
Brief Summary
-----------------
The project objective is to evaluate the impact of the recent addition of pharmacists within family medicine groups (FMGs) on organizational and clinical parameters. The process by which changes occur and the level of pharmacists' activities will also be assessed. The ultimate goal of the project is the development of an accompanying guide to facilitate the work of the pharmacist in monitoring complex patients in primary care medical clinics.

Official Title
-----------------
Proximity Work in Family Medicine Groups : the Impact of Pharmacists

Conditions
-----------------
Health Services

Intervention / Treatment
-----------------
* Other: Pharmacist clinical intervention


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Willing to meet with the pharmacist and; Consuming drugs of four or more different pharmacological classes or having to take at least four doses per day and; aged 70 or over with at least two criteria of vulnerability or aged less than 70 with at least 3 criteria of vulnerability or had a recent loss of autonomy or in post- hospitalization with medication changes in the hospital. Exclusion Criteria: None
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Pharmacist clinical intervention<br>Patients exposed to the pharmacist intervention | Other: Pharmacist clinical intervention<br>* Pharmacists will make a clinical intervention with patients. They will review patient drug therapy already prescribed in their usual care. This includes a medication reconciliation, an assessment of drug related problems, an assessment of the regimen complexity and adherence to treatment. A care plan will be elaborated. Moreover, immediate and future interventions with the patient or other health professionals will be implemented and monitored. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of drug related problems |  | 3 to 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Regimen complexity | Medication regimen complexity index (MRCI) | 3 to 6 months | 
| Medication adherence | Proportion of days covered (PDC) | 3 to 6 months | 
| Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.) | Quality indicators (proposed by INESSS) | 3 to 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
family medicine group, pharmacists, primary health care, pharmaceutical services, interprofessional relations